July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Vivek Subbiah: Obinutuzumab in Active Lupus Nephritis is a nice example of drug repurposing
Apr 20, 2025, 09:19

Vivek Subbiah: Obinutuzumab in Active Lupus Nephritis is a nice example of drug repurposing

Vivek SubbiahChief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared an article by Richard A. Furieet al. on X:

Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis:

Obinutuzumab = a humanized type II anti-CD20 monoclonal antibody approved in CLL.

A nice example of drug repurposing.”

Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis.

Authors: Richard A. Furie, et al.

Vivek Subbiah: Obinutuzumab in Active Lupus Nephritis is a nice example of drug repurposing